home / stock / inmb / inmb short
Short Information | INmune Bio Inc. (NYSE:INMB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 30,706 |
Total Actual Volume | 279,094 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,535 |
Average Short Percentage | 11.63% |
Is there a INMB Short Squeeze or Breakout about to happen?
See the INMB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $5.00 | $5.05 | $5.30 | $4.8001 | 22,030 | 5,597 | 25.41% |
02-11-2020 | $5.15 | $4.89 | $5.20 | $4.89 | 12,979 | 102 | 0.79% |
02-10-2020 | $4.96 | $5.075 | $5.25 | $4.85 | 35,299 | 3,871 | 10.97% |
02-07-2020 | $5.05 | $4.9851 | $5.09 | $4.876 | 17,276 | 8,196 | 47.44% |
02-06-2020 | $5.39 | $5.0272 | $5.40 | $4.90 | 17,544 | 340 | 1.94% |
02-05-2020 | $4.90 | $4.90 | $5.1031 | $4.90 | 7,740 | 1,222 | 15.79% |
02-04-2020 | $4.8441 | $4.7811 | $4.9123 | $4.70 | 15,667 | 500 | 3.19% |
02-03-2020 | $4.94 | $4.75 | $4.9531 | $4.75 | 12,019 | 100 | 0.83% |
01-31-2020 | $4.8614 | $4.93 | $5.00 | $4.85 | 4,282 | 1,375 | 32.11% |
01-30-2020 | $4.80 | $4.78 | $4.80 | $4.77 | 5,549 | 404 | 7.28% |
01-27-2020 | $5.03 | $4.82 | $5.0539 | $4.70 | 6,074 | 1,100 | 18.11% |
01-23-2020 | $5.29 | $4.95 | $5.32 | $4.75 | 34,088 | 553 | 1.62% |
01-22-2020 | $5.6777 | $5.2502 | $5.6777 | $5.25 | 20,294 | 1,097 | 5.41% |
01-21-2020 | $5.58 | $5.60 | $5.6216 | $5.52 | 11,951 | 518 | 4.33% |
01-17-2020 | $5.68 | $5.66 | $5.7134 | $5.65 | 10,117 | 16 | 0.16% |
01-16-2020 | $5.6101 | $5.68 | $5.8382 | $5.57 | 13,358 | 2,600 | 19.46% |
01-15-2020 | $5.6602 | $5.55 | $5.7008 | $5.53 | 7,130 | 904 | 12.68% |
01-13-2020 | $5.5578 | $5.7058 | $5.82 | $5.4607 | 8,187 | 1,071 | 13.08% |
01-10-2020 | $5.75 | $5.775 | $5.7926 | $5.5835 | 5,824 | 270 | 4.64% |
01-09-2020 | $5.4994 | $5.7362 | $5.8531 | $5.4994 | 11,686 | 870 | 7.44% |
News, Short Squeeze, Breakout and More Instantly...
The planned interim analysis confirms the accuracy of the sample size calculations and statistical power for EMACC, the primary endpoint. The interim analysis, performed by a third-party, demonstrated no need to change trial design or size. BOCA RATON, Fla., June 27, 2024 (GLOBE N...
2024-06-12 14:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Boca Raton, Florida, May 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Indexes annual r...